Home›Research›Compare›Cagrilintide vs Oxyntomodulin
Peptide ComparisonCagrilintide vs Oxyntomodulin
Both are Metabolic peptides.
Cagrilintide
AM833
Half-life: ~7 days
19 providers listed
Oxyntomodulin
OXM
No providers listed yet
Cagrilintide is carried by more providers on PeptideBase (19 vs 0); otherwise the two are closely matched on the measures we track.
Cagrilintide
Evidence
Half-life
~7 days
Oxyntomodulin
Evidence
Half-life
—
| Your goal | Better option |
|---|---|
| More provider options (19 vs 0) | Cagrilintide |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Cagrilintide
Oxyntomodulin
Cagrilintide
Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A N…
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with o…
Combination of cagrilintide and semaglutide 2·4 mg for weight management in adults with overweight and obesit…
Cagrilintide 2·4 mg once-weekly subcutaneous injection in adults with overweight or obesity (SCALE-CAGRI): a…
+6 more
Oxyntomodulin
Effects of acute moderate-intensity continuous running on circulating oxyntomodulin concentrations in healthy…
Effects of acute moderate-intensity continuous running on circulating oxyntomodulin concentrations in healthy…
Effects of acute moderate-intensity continuous running on circulating oxyntomodulin concentrations in healthy…
Oxyntomodulin reduces energy intake and adiposity in overweight and obese subjects
+7 more
About Cagrilintide
Long-acting amylin analogue; acts on amylin/calcitonin receptors to prolong satiety; synergistic with semaglutide in CagriSema combination
About Oxyntomodulin
Dual GLP-1/glucagon receptor agonist. GLP-1 component suppresses appetite; glucagon component increases energy expenditure and fatty acid oxidation. Net effect is reduced caloric intake and elevated metabolic rate.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Cagrilintide
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
Given mechanistic overlap with GLP-1 agonists when used as CagriSema, monitor thyroid C-cell markers (calcitonin), lipase for pancreatitis risk, and a baseline metabolic panel. Amylin-specific monitoring guidance is evolving as Phase 3 data matures; follow prescribing protocol of the co-administered agent.
Oxyntomodulin
Class-based (investigational)
Cagrilintide
Oxyntomodulin
Not enough vendor pricing yet.
Where to source these peptides
Cagrilintide
19 listed
Browse directory →
Providers offeringOxyntomodulin
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Metabolic Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 27, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Cagrilintide vs Oxyntomodulin — Per-mg Price Comparison. Retrieved July 29, 2026, from https://peptidebase.io/peptides/compare/cagrilintide/oxyntomodulin